Abstract

Available evidence suggests that both hydrostatic and osmotic forces are important in the development of acute respiratory distress syndrome (ARDS) or, more broadly, acute lung injury (ALI). More than 80% of ARDS patients in a large-scale randomized controlled trial (RCT) exhibited, at least intermittently, pulmonary artery wedge pressures (PAWP) above 18 mmHg. Retrospective analyses have shown that PAWP elevation is associated with increased mortality. Reduction in serum total protein (STP) has been shown, in a recent retrospective analysis of data from a sepsis patient population with a high frequency of ARDS, to be highly predictive of positive fluid balance, weight gain, development of ARDS, prolonged mechanical ventilation, and mortality. These findings suggest that therapy with diuretics and colloids might be of benefit in the prevention or treatment of ALI. A prospective RCT was designed and conducted to evaluate combination therapy with furosemide and albumin over a 5-day period in 37 ALI patients. Both mean serum albumin and mean STP increased promptly and substantially in furosemide + albumin recipients. The furosemide + albumin group also achieved a mean weight loss of 10 kg by the end of the treatment phase, and their weight loss exceeded that of placebo patients throughout. Hemodynamics improved in the treatment group during the 5-day protocol. Oxygenation, as assessed by the ratio between the fraction of inspired oxygen and the partial pressure of oxygen in arterial blood (PaO2/FiO2), was significantly higher within 24 h after commencement of treatment in the furosemide + albumin than the placebo group. No clinically important adverse effects of furosemide + albumin therapy were encountered. These results provide evidence that combined therapy with furosemide and albumin is effective in augmenting serum albumin and STP levels, promoting weight loss, and improving oxygenation and longer-term hemodynamic stability. Although mortality did not differ between groups, the RCT showed a trend toward reduced duration of mechanical ventilation and length of stay in the intensive care unit in patients receiving furosemide + albumin. The findings of the RCT further highlight the importance of both hydrostatic and osmotic forces in hypoxemic respiratory failure, a subject that requires further investigation.

Highlights

  • Both hydrostatic and osmotic forces are at play in the development of acute respiratory distress syndrome (ARDS) or, more broadly, acute lung injury (ALI)

  • Hydrostatic pressure is a key contributor to the formation of edema regardless of the integrity of the capillary barrier, it exerts an exaggerated effect in states of increased capillary permeability, which is a pathognomonic hallmark of ARDS or ALI

  • Furosemide and albumin in ALI: design of a randomized controlled trial (RCT) The evidence already reviewed supports the concept that reduction in hydrostatic forces and maintenance of normal colloid osmotic pressure might improve clinical outcomes in ALI patients

Read more

Summary

Introduction

Both hydrostatic and osmotic forces are at play in the development of ARDS or, more broadly, ALI. Furosemide and albumin in ALI: design of a RCT The evidence already reviewed supports the concept that reduction in hydrostatic forces and maintenance of normal colloid osmotic pressure might improve clinical outcomes in ALI patients This evidence suggests that combined diuretic and colloid therapy may benefit ALI patients. The pronounced changes in serum albumin, STP and body weight associated with the furosemide + albumin regimen were not accompanied by evidence of renal dysfunction, as judged by the lack of significant betweengroup difference in blood urea nitrogen or creatinine These patients did, exhibit electrolyte effects typical of diuretic treatment. Three patients died in each study group, and the mortality rate of the furosemide + albumin group (16%) was similar to that of the placebo group (17%)

Conclusion
Findings
Brater DC
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.